Identification of cis-Acting Repressor Activity within Human Immunodeficiency Virus Type 1 Protease Sequences

By Huffman K.M.   Arrigo S.J.  

Virology, Vol. 234, Iss. 2, 1997-08 ,pp. : 253-260

Elsevier

Access to resources Recommend Favorite

Virological Importance of the Protease-Cleavage Site in Human Immunodeficiency Virus Type 1 Nef Is Independent of both Intravirion Processing and CD4 Down-regulation

By Pandori M.   Craig H.   Moutouh L.   Corbeil J.   Guatelli J.  

Virology, Vol. 251, Iss. 2, 1998-11 ,pp. : 302-316

Elsevier

Access to resources Recommend Favorite

Human Serum Attenuates the Activity of Protease Inhibitors toward Wild-Type and Mutant Human Immunodeficiency Virus

By Molla A.   Vasavanonda S.   Kumar G.   Sham H.L.   Johnson M.   Grabowski B.   Denissen J.F.   Kohlbrenner W.   Plattner J.J.   Leonard J.M.   Norbeck D.W.   Kempf D.J.  

Virology, Vol. 250, Iss. 2, 1998-10 ,pp. : 255-262

Elsevier

Access to resources Recommend Favorite

Fitness of Human Immunodeficiency Virus Type 1 Protease Inhibitor-Selected Single Mutants

By Martinez-Picado J.   Savara A.V.   Shi L.   Sutton L.   D'Aquila R.T.  

Virology, Vol. 275, Iss. 2, 2000-09 ,pp. : 318-322

Elsevier

Access to resources Recommend Favorite

Virion Incorporation of Human Immunodeficiency Virus Type-1 Vif Is Determined by Intracellular Expression Level and May Not Be Necessary for Function

By Simon J.H.M.   Miller D.L.   Fouchier R.A.M.   Malim M.H.  

Virology, Vol. 248, Iss. 2, 1998-09 ,pp. : 182-187

Elsevier

Access to resources Recommend Favorite